-

Lost Money in The Chemours Company? Gibbs Law Group Investigates Potential Securities Law Violations

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of The Chemours Company (“Chemours”) dropped over 12% in intraday trading on February 14, 2024, after announcing it is evaluating its internal control over financial reporting and postponing its fourth quarter and full year 2023 financial results. Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC).

What Should Chemours Company Investors Do?

If you invested in The Chemours Company, visit our website by clicking here, or call us toll-free at (888) 410-2925 to discuss how you may be able to recover your losses. Our investigation concerns whether Chemours Company has violated federal securities laws by providing false or misleading statements to investors.

What is The Chemours Company Securities Lawsuit Investigation About?

After the market closed on February 13, 2024, Chemours announced that it is delaying the release of its fourth quarter and full year 2023 financial results in part because it needs to evaluate its internal control over financial reporting as of December 31, 2023. According to the announcement, these financial results were previously scheduled to be released on February 14, 2024, and February 15, 2024, and have been delayed until after the market close on Wednesday, February 28, 2024. The company also disclosed that these financial results are delayed in part because the company’s Audit Committee requires additional time for internal review.

Following Chemours’ announcement, the stock dropped over 12% in intraday trading on February 14th, causing harm to investors.

About Gibbs Law Group

Gibbs Law Group represents investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

Gibbs Law Group

NYSE:CC

Release Summary
Gibbs Law Group is investigating potential legal claims on behalf of Chemours Company (NYSE: CC) investors. Call (888) 410-2925.
Release Versions
$Cashtags
Hashtags

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

More News From Gibbs Law Group

Top Plaintiff Firms Join Forces for Law Students: The Mason Gibbs Plaintiffs' Pathway Fellowship

OAKLAND, Calif.--(BUSINESS WIRE)--The Mason Gibbs Plaintiffs’ Pathway Fellowship has now launched, offering exceptional 1L law students the opportunity to spend their summer at leading plaintiff firms across the country holding corporations accountable for misconduct and protecting the rights of ordinary individuals. Students will have the opportunity to be placed in the summer of 2026 at Gibbs Mura LLP, in Oakland, CA; Singleton Schreiber, with 17 offices in different cities; Koskoff Koskoff &...

Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Ardent Health, Inc. (NYSE: ARDT) investors....

Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces that a class action lawsuit has been filed against Stride, Inc. (“Stride”) on behalf of investors who purchased or acquired Stride securities between October 22, 2024 and October 28, 2025. Shares of Stride, Inc. plummeted over 51% in intraday trading on October 29, 2025, after the company reported a weak 2026 financial forecast, citing platform upgrades that resulted in a “poor customer experience” and a large decrease in enrollment numbers...
Back to Newsroom